Northern Trust Corp Gsk PLC Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$42.05 - $47.77 $668,552 - $759,495	-15,899 Reduced 0.84%	1,872,325 $81.5 Million
Q1 2022 May 13, 2022	SELL	$40.23 - $47.74 $7.94 Million - $9.43 Million	-197,484 Reduced 9.47%	1,888,224 $82.3 Million
Q4 2021 Feb 08, 2022	BUY	$38.88 - $45.31 $8.11 Million - $9.45 Million	208,568 Added 11.11%	2,085,708 $92 Million
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $7.57 Million - $8.42 Million	-195,115 Reduced 9.42%	1,877,140 $71.7 Million
Q2 2021 Aug 13, 2021	SELL	$36.52 - $41.46 $18.5 Million - $21 Million	-505,604 Reduced 19.61%	2,072,255 $82.5 Million
Q1 2021 May 12, 2021	BUY	$34.27 - $40.01 $4.04 Million - $4.72 Million	117,975 Added 4.8%	2,577,859 $92 Million
Q4 2020 Feb 11, 2021	SELL	$34.07 - $39.94 $3.93 Million - $4.6 Million	-115,228 Reduced 4.47%	2,459,884 $90.5 Million
Q3 2020 Nov 16, 2020	BUY	$38.11 - $42.99 $427,556 - $482,304	11,219 Added 0.44%	2,575,112 $96.9 Million
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $4.89 Million - $5.63 Million	-129,186 Reduced 4.8%	2,563,893 $105 Million
Q1 2020 May 14, 2020	SELL	$32.47 - $48.83 $2.27 Million - $3.41 Million	-69,890 Reduced 2.53%	2,693,079 $102 Million
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $2.06 Million - $2.37 Million	49,114 Added 1.81%	2,762,969 $130 Million
Q3 2019 Nov 13, 2019	BUY	$40.46 - $43.52 $3.02 Million - $3.24 Million	74,563 Added 2.83%	2,713,855 $116 Million
Q2 2019 Aug 13, 2019	SELL	$39.4 - $42.7 $438,443 - $475,165	-11,128 Reduced 0.42%	2,639,292 $106 Million
Q1 2019 May 13, 2019	SELL	$38.57 - $42.69 $6.08 Million - $6.73 Million	-157,551 Reduced 5.61%	2,650,420 $111 Million
Q4 2018 Feb 12, 2019	SELL	$37.8 - $42.69 $5.22 Million - $5.9 Million	-138,107 Reduced 4.69%	2,807,971 $107 Million
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $2.96 Million - $3.17 Million	74,350 Added 2.59%	2,946,078 $118 Million
Q2 2018 Sep 18, 2018	SELL	$39.61 - $42.76 $6.42 Million - $6.93 Million	-162,096 Reduced 5.34%	2,871,728 $116 Million
Q2 2018 Aug 14, 2018	SELL	$39.61 - $42.76 $6.85 Million - $7.39 Million	-172,840 Reduced 5.39%	3,033,824 $122 Million
Q1 2018 May 09, 2018	BUY	$36.18 - $40.15 $11.1 Million - $12.3 Million	306,441 Added 10.57%	3,206,664 $125 Million
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $6.05 Million - $7.17 Million	-171,177 Reduced 5.57%	2,900,223 $103 Million
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $121 Million - $128 Million	3,071,400	3,071,400 $125 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account